Kaempferitrin alleviates LPS-induced septic acute lung injury in mice through downregulating NF-κB pathway
Allergologia et Immunopathologia · 2023
DOI: 10.15586/aei.v51i6.838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2023. Verfasst von Xiaoli Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Medicine, Zhejiang Youth Hospital, Hangzhou, Zhejiang Province, China; Zhuxiaoli_666@163.com. Hauptthemen laut MEDLINE: Acute Lung Injury, Pneumonia. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Acute lung injury (ALI) causes severe and uncontrolled pulmonary inflammation and has high morbidity in dying patients.
Objective
This study aimed to evaluate the potential function of Kaempferitrin (Kae) and uncover its mechanisms in ALI. Material and Methods: We evaluated the role of Kae in ALI through the lipopolysaccharide (LPS)-induced histopathological changes, lung wet/dry (W/D) ratio, total bronchoalveolar lavage fluid (BALF) cells count, pulmonary inflammation, and the levels of interleukin (IL)-6, tumor necrosis factor-α (TNF-α), and IL-1β. The effect of Kae on NF-κB signaling pathway was discovered through the protein expression levels of transcription factors p65, p-p65, IκBα, and p-IκBα by Western blot analysis.
Results
The results showed that Kae could improve lung injury by reducing apoptosis, histopathological changes, and lung W/D ratio; more importantly, Kae enhanced the survival of ALI mice. Moreover, Kae relieved inflammation, as it reduced total BALF cells count, and deceased the levels of TNF-α, IL-6, and IL-1β in serum. In addition, Western blot analysis data suggested that Kae could decrease the protein expression levels of transcription factors p65, p-p65, IκB-α, and p-IκB-α, which were promoted by LPS.
Conclusion
The results of this study suggested that Kae could relieve LPS-induced ALI in mice and reduce inflammation and apoptosis through NF-κB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Critical Care Medicine, Zhejiang Youth Hospital, Hangzhou, Zhejiang Province, China; Zhuxiaoli_666@163.com.
- Critical Care Medicine, Zhejiang Youth Hospital, Hangzhou, Zhejiang Province, China.
- Critical Care Medicine, Zhejiang Chinese Medicine University, Hangzhou, Zhejiang Province, China.
Zitieren
APA
Zhu, X., Pan, Y., Xu, X., & Xu, J. (2023). Kaempferitrin alleviates LPS-induced septic acute lung injury in mice through downregulating NF-κB pathway. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v51i6.838
Vancouver
Zhu X, Pan Y, Xu X, Xu J. Kaempferitrin alleviates LPS-induced septic acute lung injury in mice through downregulating NF-κB pathway. Allergologia et Immunopathologia. 2023. doi:10.15586/aei.v51i6.838
BibTeX
@article{Zhu2023,
author = {Zhu, Xiaoli and Pan, Yongyue and Xu, Xin and Xu, Jing},
title = {Kaempferitrin alleviates LPS-induced septic acute lung injury in mice through downregulating NF-κB pathway},
journal = {Allergologia et Immunopathologia},
year = {2023},
doi = {10.15586/aei.v51i6.838}
}
EUVIMED